Fentanyl Correction
In the Medical Letter article Drugs for Pain (vol. 40, page 84, August 14, 1998), the last comment on fentanyl in the table is incorrect. Fentanyl Oralet has not been approved by the FDA for treatment of breakthrough pain.
This article has been freely provided.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Fentanyl Correction
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1036
Article Code: 1036d
Date: September 25, 1998
Volume: 40
Page: 96
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1036
Article Code: 1036d
Date: September 25, 1998
Volume: 40
Page: 96
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article.This article is not available for purchase.